PRGOPERRIGO Co plc

NYSE perrigo.com


$ 27.53 $ 0.24 (0.86 %)    

Friday, 31-May-2024 15:59:55 EDT
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 27.53
$ 27.41
$ 27.51 x 200
$ 27.52 x 101
$ 27.41 - $ 27.74
$ 25.26 - $ 38.83
1,752,160
na
3.71B
$ 0.70
nm
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-30-2024 10-Q
2 02-27-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 07-01-2023 10-Q
5 05-09-2023 04-01-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 10-01-2022 10-Q
8 08-09-2022 07-02-2022 10-Q
9 05-11-2022 04-02-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-12-2021 10-02-2021 10-Q
12 08-11-2021 07-03-2021 10-Q
13 05-12-2021 04-03-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-05-2020 09-26-2020 10-Q
16 08-05-2020 06-27-2020 10-Q
17 05-05-2020 03-28-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-28-2019 10-Q
20 08-08-2019 06-29-2019 10-Q
21 05-09-2019 03-30-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-08-2018 09-29-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-10-2017 07-01-2017 10-Q
29 05-30-2017 04-01-2017 10-Q
30 05-22-2017 12-31-2016 10-K
31 11-10-2016 10-01-2016 10-Q
32 08-10-2016 07-02-2016 10-Q
33 05-16-2016 04-02-2016 10-Q
34 11-02-2015 09-26-2015 10-Q
35 08-13-2015 06-27-2015 10-K
36 04-29-2015 03-28-2015 10-Q
37 02-05-2015 12-27-2014 10-Q
38 11-06-2014 09-27-2014 10-Q
39 08-14-2014 06-28-2014 10-K
40 05-07-2014 03-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 donald-j-trump-posts-on-truth-i-have-never-and-will-never-advocate-imposing-restrictions-on-birth-control-or-other-contraceptives-this-is-a-democrat-fabricated-lie-misinformationdisinformation-because-they-have-nothing-else-to-run-on-except-failure-poverty-and-death-i-do-not-support-a-ban-on-birth-control-and-neither-will-the-republican-party

https://truthsocial.com/@realDonaldTrump/posts/112480398507581671  

 perrigo-secures-binding-offer-to-divest-its-hra-pharma-rare-diseases-business-for-up-to-275m

The total consideration of up to €275 million, consisting of an upfront cash payment of €190 million and up to €85 million in p...

 canaccord-genuity-maintains-buy-on-perrigo-maintains-42-price-target

Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and maintains $42 price target.

 disney-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 piper-sandler-maintains-overweight-on-perrigo-raises-price-target-to-39

Piper Sandler analyst Korinne Wolfmeyer maintains Perrigo (NYSE:PRGO) with a Overweight and raises the price target from $35...

 cvs-healths-zero-cost-coverage-paves-way-for-otc-birth-control-access

CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without ...

Core News & Articles

-Bloomberg

Core News & Articles

https://www.washingtonpost.com/politics/2024/03/26/abortion-pill-supreme-court-arguments-mifepristone/The Supreme Court on Tues...

 perrigo-commences-shipments-of-opill-to-retailers-nationwide

Opill®, the first ever daily birth control pill available without a prescription in the United States, will be available in-sto...

 around-2m-bet-on-tile-shop-holdings-check-out-these-4-stocks-insiders-are-buying

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

 perrigo-form4-filing-shows-ceo-taylor-patrick-lockwood-purchased-9500-shares-at-an-average-price-of-2654-per-share

- SEC Filing

 jp-morgan-maintains-overweight-on-perrigo-lowers-price-target-to-41

JP Morgan analyst Chris Schott maintains Perrigo (NYSE:PRGO) with a Overweight and lowers the price target from $48 to $41.

 otc-medicine-player-perrigo-outlines-three-year-cost-saving-plan-posts-mixed-q4-earnings

Perrigo Q4 2023 net sales reach $1.2 billion, up 0.1% YoY. Explore Project Energize for long-term growth.

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

 perrigo-will-launch-project-energize-investment-and-efficiency-program-in-q1-2024-to-drive-its-one-perrigo-sustainable-value-accretive-growth-strategy--restructuring-is-expected-to-impact-approximately-6-of-perrigo-roles

Project Energize will be initiated in Q1 2024, subject to local law and consultation requirements, and is expected to deliver a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION